Covered recipient · General Payments record
MARIA I NASH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,829.42
- Reported across 324 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $288.98 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $88.33 | 5 |
| ABBVIE INC. | $62.97 | 3 |
| Lilly USA, LLC | $53.16 | 3 |
| PFIZER INC. | $29.97 | 2 |
| Acerta Pharma LLC | $14.10 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.68 | 1 |
| Novo Nordisk AS | $13.46 | 1 |
| DEXCOM, INC. | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101695 | CMS |
| ABBVIE INC. | $19.41 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101697 | CMS |
| ABBVIE INC. | $27.56 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101699 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.10 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105826217 | CMS |
| Dexcom, Inc. | $13.31 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153319254 | CMS |
| GlaxoSmithKline, LLC. | $18.46 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116605448 | CMS |
| GlaxoSmithKline, LLC. | $18.53 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116435771 | CMS |
| GlaxoSmithKline, LLC. | $16.53 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116201518 | CMS |
| GlaxoSmithKline, LLC. | $16.43 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115919183 | CMS |
| GlaxoSmithKline, LLC. | $18.38 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116229251 | CMS |
| Lilly USA, LLC | $21.73 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135153540 | CMS |
| Lilly USA, LLC | $13.88 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135165535 | CMS |
| Lilly USA, LLC | $17.55 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135110736 | CMS |
| Novo Nordisk Inc | $13.46 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096699504 | CMS |
| PFIZER INC. | $15.00 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131728875 | CMS |
| PFIZER INC. | $14.97 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131873857 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.68 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151100939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.